NEW HAVEN, Conn. (AP) _ Melinta Therapeutics, Inc. (MLNT) on Thursday reported a loss of $26.5 million in its first quarter.
On a per-share basis, the New Haven, Connecticut-based company said it had a loss of $2.34.
The drugmaker posted revenue of $14.1 million in the period.
In the final minutes of trading on Thursday, the company's shares hit $4.62. A year ago, they were trading at $37.50.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MLNT at https://www.zacks.com/ap/MLNT